tm
Seeing Is Believing
tm
Seeing Is Believing
ENLV is currently covered by 2 analysts with an average price target of $10.07. This is a potential upside of $9.05 (887.25%) from yesterday's end of day stock price of $1.02.
Enlivex Therapeutics Ltd's activity chart (see below) currently has 5 price targets and 18 ratings on display. The stock rating distribution of ENLV is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 11.11% with an average time for these price targets to be met of 183 days.
Highest price target for ENLV is $13, Lowest price target is $7, average price target is $10.
Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 20-Apr-2025. First documented stock forecast 08-Jan-2020.
Currently out of the existing stock ratings of ENLV, 14 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$13
$11.98 (1174.51%)
$13
21 days ago
(20-Apr-2025)
0/3 (0%)
$12.12 (1377.27%)
Buy
$7
$5.98 (586.27%)
$6
1 months 18 days ago
(23-Mar-2025)
2/9 (22.22%)
$5.98 (586.27%)
366
What is ENLV (Enlivex Therapeutics Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on ENLV (Enlivex Therapeutics Ltd) with a proven track record?
Which analyst has the current lower performing score on ENLV (Enlivex Therapeutics Ltd) with a proven track record?
Which analyst has the most public recommendations on ENLV (Enlivex Therapeutics Ltd)?
Which analyst is the currently most bullish on ENLV (Enlivex Therapeutics Ltd)?
Which analyst is the currently most reserved on ENLV (Enlivex Therapeutics Ltd)?
